Invenomic Capital Management’s M&T Bank MTB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.63M Sell
23,644
-5,344
-18% -$1.17M 0.34% 82
2026
Q1
$5.99M Sell
28,988
-145,519
-83% -$31.3M 0.27% 93
2025
Q4
$35.2M Buy
174,507
+27,540
+19% +$5.26M 1.64% 17
2025
Q3
$29M Sell
146,967
-11,086
-7% -$2.18M 1.41% 20
2025
Q2
$30.7M Buy
158,053
+73,388
+87% +$12.9M 1.74% 13
2025
Q1
$15.1M Sell
84,665
-11,810
-12% -$2.24M 0.76% 45
2024
Q4
$18.1M Sell
96,475
-185,291
-66% -$36.8M 0.86% 31
2024
Q3
$50.2M Buy
281,766
+98,930
+54% +$16.4M 2.76% 2
2024
Q2
$27.7M Buy
182,836
+117,663
+181% +$17.2M 1.35% 17
2024
Q1
$9.48M Buy
+65,173
New +$9.03M 0.5% 70

Other funds holding MTB

Invenomic Capital Management's MTB Position: Q2 2026 in Review

Invenomic Capital Management reduced its M&T Bank (MTB) stake by 18% in Q2 2026, selling an estimated $1.17M and leaving 23,644 shares worth $5.63M. The position accounts for 0.34% of the portfolio, ranked #82.

Invenomic Capital Management first reported a position in MTB in Q1 2024 and has held it in 10 quarters since. The position peaked at $50.2M in Q3 2024. 1,161 funds tracked by Wall St. Rank hold MTB as of Q2 2026.

  • Invenomic Capital Management held 23,644 shares of M&T Bank worth $5.63M as of Q2 2026.
  • Invenomic Capital Management sold 5,344 M&T Bank shares in Q2 2026, an estimated $1.17M.
  • M&T Bank made up 0.34% of Invenomic Capital Management's portfolio in Q2 2026, its #82 holding.
  • Invenomic Capital Management first reported a position in M&T Bank in Q1 2024 and has held it in 10 quarters since.
  • Invenomic Capital Management's M&T Bank position peaked at $50.2M in Q3 2024.
  • 1,161 funds tracked by Wall St. Rank held M&T Bank as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.